Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Agilon Health, Inc. (AGL : NYSE)

• Company Description    agilon health inc. which partners with primary care physicians to provide healthcare services. agilon health inc. is based in CA, United States. Number of Employees: 648

• Price / Volume Information    Yesterday's Closing Price: $18.75 Daily Weekly Monthly 20 Day Moving Average: 2,100,523 shares Shares Outstanding: 406.73 (millions) Market Capitalization: $7,626.20 (millions) Beta: 52 Week High: $44.83 52 Week Low: $14.36 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -13.56% -1.75% 12 Week 5.40% 13.50% Year To Date -30.56% -15.64%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 6210 E HWY 290 SUITE 450 - AUSTIN,TX 78723 USA ph: 562-256-3800 fax: - investors@agilonhealth.com http://agilonhealth.com

• General Corporate Information    Officers Steven J. Sell - Chief Executive Officer; President and Director Ronald A. Williams - Chairman Ravi Sachdev - Vice Chairman Timothy S. Bensley - Executive Vice President and Chief Financial Offic Glenn W. Sobotka - Chief Accounting Officer Peer Information Agilon Health, Inc. (CHCR) Agilon Health, Inc. (ESRX) Agilon Health, Inc. (MYDP) Agilon Health, Inc. (GBCS) Agilon Health, Inc. (LAXAF) Agilon Health, Inc. (IPCM) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: 00857U107 SIC: 8090 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/22 Next Expected EPS Date: 08/03/22 Share - Related Items Shares Outstanding: 406.73 Most Recent Split Date: (:1) Beta: Market Capitalization: $7,626.20 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.02 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.11 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 6.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/03/22

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 6.76 Price/Cash Flow: - Price / Sales: 3.68 EPS Growth vs. Year Ago Period: 100.00% vs. Previous Quarter: 100.00% Sales Growth vs. Year Ago Period: 58.18% vs. Previous Quarter: 41.17% ROE 03/31/22 - -10.34 12/31/21 - -17.01 09/30/21 - -26.63 ROA 03/31/22 - -7.01 12/31/21 - -9.42 09/30/21 - -10.24 Current Ratio 03/31/22 - - 12/31/21 - 3.83 09/30/21 - 3.44 Quick Ratio 03/31/22 - - 12/31/21 - 3.83 09/30/21 - 3.44 Operating Margin 03/31/22 - -5.60 12/31/21 - -7.12 09/30/21 - -6.67 Net Margin 03/31/22 - -18.81 12/31/21 - -22.17 09/30/21 - -22.11 Pre-Tax Margin 03/31/22 - - 12/31/21 - -22.07 09/30/21 - -22.83 Book Value 03/31/22 - - 12/31/21 - 2.77 09/30/21 - 2.86 Inventory Turnover 03/31/22 - - 12/31/21 - - 09/30/21 - - Debt-to-Equity 03/31/22 - - 12/31/21 - 0.04 09/30/21 - 0.04 Debt-to-Capital 03/31/22 - - 12/31/21 - 3.82 09/30/21 - 3.81

Powered by Zacks Investment Research ©